Enhancing the Genetic Testing Power by Next-Generation Sequencing

Genetech Biotech Co., Ltd., introducing sequencing solutions of leading edge such as illumina and 10x Genomics, devote our efforts to the development of precision medicine.

Next-Generation Sequencing: illumina launched a new generation sequencing platform NextSeq 2000, which provides an entire workflow from sequencing to data analysis, suitable for large genome analysis, whole-exome sequencing, and whole-transcriptome sequencing.

Single cell sequencing: 10x Genomics provides a variety of single-cell sequencing solutions, which can identify the population, subtype, and gene expression of a single cell, explore immune repertoires, and assist in the development of antibody drugs.

Circulating tumor cells enrichment: ClearCell FX1 uses label-free microfluidic technology to capture circulating tumor cells with high viability, which can be subsequently used for cell culture, genomic and proteomic analysis, and PDX model establishment.

Tissue transcriptome/proteome analysis: Visium Spatial Gene Expression can identify the cell type and gene expression in tissue samples simultaneously. Cell DIVE can observe dozens of biomarkers on single tissue section, analyze spatial protein expression at the single cell level, and restore the tumor microenvironment for tumor heterogeneity analysis.

  Visit us at the Diagnostics, gene & cell therapy pavilion  

 Look for: Next-generation Sequencing solutions, cancer research and detections, agents/distributors consult